Search
Linvencorvir
go.drugbank.com/drugs/DB21544InvestigationalLinvencorvir has a monoisotopic molecular weight of 598.24 Da. … Linvencorvir is a small molecule drug. The usage of the INN stem '-corvir' in the name indicates that Linvencorvir is a core protein (Cp) inhibitor.
Fipravirimat
go.drugbank.com/drugs/DB21578InvestigationalFipravirimat has a monoisotopic molecular weight of 726.48 Da. … Fipravirimat is a small molecule drug. The usage of the INN stem '-virimat' in the name indicates that Fipravirimat is a antiviral, disruptor of viral maturation.
Opnurasib
go.drugbank.com/drugs/DB21583InvestigationalOpnurasib has a monoisotopic molecular weight of 525.2 Da. … Opnurasib is a small molecule drug. The usage of the INN stem '-rasib' in the name indicates that Opnurasib is a Ras protein inhibitor.
Relutrigine
go.drugbank.com/drugs/DB21614InvestigationalRelutrigine has a monoisotopic molecular weight of 407.08 Da. … Relutrigine is a small molecule drug. The usage of the INN stem '-trigine' in the name indicates that Relutrigine is a sodium channel blocker, signal transduction modulator.
Foselutoclax
go.drugbank.com/drugs/DB21663InvestigationalFoselutoclax has a monoisotopic molecular weight of 1158.28 Da. … Foselutoclax is a small molecule drug. The usage of the INN stem '-toclax' in the name indicates that Foselutoclax is a B-cell lymphoma 2 (Bcl-2) inhibitor.
Omburtamab
go.drugbank.com/drugs/DB15635InvestigationalCD276 (B7-H3) is a B7/CD28 immunoglobulin superfamily member frequently expressed among solid human tumours.
Polaprezinc
go.drugbank.com/drugs/DB09221InvestigationalPolaprezinc is a chelated form of zinc and L-carnosine. It is a zinc-related medicine approved for the first time in Japan, which has been clinically used to treat gastric ulcers [L1307, L1308]. … A study in 2013 showed that CO-administration of polaprezinc may be effective against small intestine mucosal injury associated with long-term aspirin therapy [A7840].
Bleomycin A6
go.drugbank.com/drugs/DB12992InvestigationalIt was developed in China as an antineoplastic antibiotic. This drug participated in clinical trials for the treatment of Squamous Cell Lung Cancer.
1D09C3
go.drugbank.com/drugs/DB05121Experimental1D09C3, a monoclonal antibody against lymphoid cancers, is an anti-MHC (major histocompatibility complex) class II monoclonal antibody. … selectively killing activated, proliferating MHC class II-positive tumor cells, which include those in B-cell and T-cell lymphomas. 1D09C3 has been shown to induce programmed cell death and does not require a
Fulzerasib
go.drugbank.com/drugs/DB21609InvestigationalFulzerasib has a monoisotopic molecular weight of 630.22 Da. … Fulzerasib is a small molecule drug. The usage of the INN stem '-rasib' in the name indicates that Fulzerasib is a Ras protein inhibitor.